Leuk Res 1997, 21:147–152.PubMedCrossRef 13. Siegel DS, Zhang X, Feinman R, Teitz T, Zelenetz A, Richon VM, Rifkind RA, Marks PA, Michaeli J: Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cells. Proc Natl Acad Sci USA 1998, 95:162–166.PubMedCrossRef 14. Henkels KM, Turchi JJ: Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. Cancer Res 1999, 59:3077–3083.PubMed 15. Hamilton G, Cosentini EP, Teleky B, Koperna T, Zacheri J, Riegler M, Feil W, Schiessel R, Wenzi E: The multidrug-resistance modifiers verapamil, cyclosporine

A and tamoxifen induce an intracellular acidification in colon carcinoma cell lines in vitro. Anticancer Res 1993, 13:2059–2063.PubMed 16. Urbatsch IL, Selleckchem YH25448 Sankaran B, Weber J, Senior AE: P-glycoprotein is stably inhibited by

vanadate-induced trapping of nucleotide at a single catalytic site. J Biol Chem 1995, 270:19383–19390.PubMedCrossRef 17. Sun YL, Zhou GY, Li KN, Gao P, Zhang QH, Zhen JH, Bai YH, Zhang XF: Suppression of glucosylceramide synthase by RNA interference reverses multidrug resistance in human breast cancer cells. Neoplasma 2006, 53:1–8.PubMed 18. Chin KV, Ueda K, Pastan I, Gottesman MM: Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 1992, 255:459–462.PubMedCrossRef 19. Nooter K, Boersma AW, Oostrum RG, Burger H, Jochemsen AG, Stoter PX-478 cost G: Constitutive expression of the c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line. Br J Cancer 1995, 71:556–561.PubMedCrossRef 20. Di Simone D, Galimberti S, Basolo F, Ciardiello F, Petrini M, Scheper RJ: c-Ha-ras transfection and expression of MDR-related genes in MCF-10A human breast cell line. Anticancer Res 1997, 17:3587–3592.PubMed 21. Ejendal KF, Hrycyna CA: Multidrug resistance and cancer: the role of the human ABC transporter ABCG2. Curr Protein Pept Sci 2002, 3:503–511.PubMedCrossRef

until 22. Eckhardt S: Recent progress in the development of anticancer agents. Curr Med Chem Anticancer Agents 2002, 2:419–439.PubMedCrossRef 23. Choi JH, Lim HY, Joo HJ, Kim HS, Yi JW, Kim HC, Cho YK, Kim MW, Lee KB: Expression of multidrug resistance-associated protein1, P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection. Br J Cancer 2002, 86:1578–1585.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions XGZ carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. MMX participated in the sequence alignment. RHG participated in the design of the study and performed the statistical analysis.